Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2003;34:2935-2940
Published online before print November 20, 2003, doi: 10.1161/01.STR.0000103747.58719.59
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
34/12/2935    most recent
01.STR.0000103747.58719.59v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hénon, H.
Right arrow Articles by Leys, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hénon, H.
Right arrow Articles by Leys, D.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Dementia
*Stroke
Related Collections
Right arrow Risk Factors for Stroke

(Stroke. 2003;34:2935.)
© 2003 American Heart Association, Inc.


Original Contributions

Leukoaraiosis More Than Dementia Is a Predictor of Stroke Recurrence

H. Hénon, MD, PhD; P. Vroylandt, MD; I. Durieu, MD; F. Pasquier, MD, PhD D. Leys, MD

From the Department of Neurology, Stroke Unit (H.H., P.V., I.D., D.L.), and Memory Clinic (H.H., F.P.), University of Lille, Lille, France.

Reprint requests to Hilde Hénon, MD, PhD, Department of Neurology, Stroke Unit, Hôpital Roger Salengro, F-59037 Lille, France. E-mail hhenon{at}chru-lille.fr

Background and Purpose— It has been suggested that poststroke dementia is associated with a higher risk of stroke recurrence. Leukoaraiosis, however, might be a confounding factor because it is a risk factor for stroke recurrence and cognitive decline. Our aim was to determine the influence of prestroke and poststroke dementia on the 3-year risk of stroke recurrence.

Methods— We evaluated prestroke cognitive functions in 202 stroke patients >=40 years of age using the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), with a cutoff of 104 for the diagnosis of dementia. Patients were followed up for 3 years. Dementia was diagnosed on the basis of International Classification of Diseases, 10th revision, criteria in survivors who underwent a neurologist visit or from the IQCODE score in survivors who did not. The severity of leukoaraiosis was assessed with a visual rating scale on CT scans without contrast performed at the acute stage of stroke. At each follow-up contact, stroke recurrences were recorded.

Results— During 385 person-years of follow-up, a total of 29 patients developed 33 stroke recurrences, resulting in an incidence rate of 8.6 per 100 person-years. We did not find any influence of dementia on the risk of stroke recurrence. Leukoaraiosis, however, was a strong predictor of stroke recurrence within 3 years after stroke.

Conclusions— Dementia was not a predictor of stroke recurrence, but leukoaraiosis was strongly associated with stroke recurrence. Special attention in the secondary prevention of stroke must be given to patients with leukoaraiosis with or without dementia.


Key Words: dementia • leukoaraiosis • recurrence • stroke • white matter




This article has been cited by other articles:


Home page
RadiologyHome page
N. Altaf, P. S. Morgan, A. Moody, S. T. MacSweeney, J. R. Gladman, and D. P. Auer
Brain White Matter Hyperintensities Are Associated with Carotid Intraplaque Hemorrhage
Radiology, July 1, 2008; 248(1): 202 - 209.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. Lin, L. Svensson, R. Gupta, B. Lytle, and D. Krieger
Chronic ischemic cerebral white matter disease is a risk factor for nonfocal neurologic injury after total aortic arch replacement
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1059 - 1065.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
M Pasquini, D Leys, M Rousseaux, F Pasquier, and H Henon
Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke
J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 56 - 59.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
W. K. Tang, S. S. M. Chan, H. F. K. Chiu, G. S. Ungvari, K. S. Wong, T. C. Y. Kwok, V. Mok, K. T. Wong, P. S. Richards, and A. T. Ahuja
Frequency and clinical determinants of poststroke cognitive impairment in nondemented stroke patients.
J Geriatr Psychiatry Neurol, June 1, 2006; 19(2): 65 - 71.
[Abstract] [PDF]


Home page
StrokeHome page
T. del Ser, R. Barba, M. M. Morin, J. Domingo, C. Cemillan, M. Pondal, and J. Vivancos
Evolution of Cognitive Impairment After Stroke and Risk Factors for Delayed Progression
Stroke, December 1, 2005; 36(12): 2670 - 2675.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Leys and S Bombois
White matter hyperintensities: a target for the prevention of cognitive decline?
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(9): 1185 - 1186.
[Full Text] [PDF]